Chemed (NYSE:CHE) Reaches New 52-Week High - What's Next?

Key Points

• Chemed shares hit a new 52-week high, trading as high as $497.25 on Thursday and closing near $492.96. The move came on above-average attention, with about 123,949 shares changing hands.
• Recent analyst sentiment has been mixed but generally cautious: multiple firms raised price targets, yet the overall consensus remains a Hold with an average target price of $480.25. Bank of America recently lifted its target to $510, while Royal Bank of Canada moved to $436.
• The company beat quarterly EPS expectations, reporting $5.65 versus $5.30 estimated, and also recently paid a quarterly dividend of $0.60 per share. Chemed’s low debt load and strong return on equity were also highlighted in the report.

Chemed Corporation (NYSE:CHE - Get Free Report) shares reached a new 52-week high during trading on Thursday . The stock traded as high as $497.25 and last traded at $492.96, with a volume of 123949 shares trading hands. The stock had previously closed at $491.89.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on CHE. Royal Bank Of Canada increased their price objective on shares of Chemed from $422.00 to $436.00 and gave the stock a "sector perform" rating in a report on Monday, April 27th. Weiss Ratings upgraded shares of Chemed from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, April 29th. Wall Street Zen lowered shares of Chemed from a "buy" rating to a "hold" rating in a research report on Monday, June 8th. Bank of America increased their price target on shares of Chemed from $450.00 to $510.00 and gave the stock a "neutral" rating in a research note on Thursday, July 9th. Finally, Zacks Research upgraded shares of Chemed from a "strong sell" rating to a "hold" rating in a report on Monday, April 27th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $480.25.

Chemed Stock Performance

The company has a market capitalization of $6.54 billion, a price-to-earnings ratio of 26.86, a price-to-earnings-growth ratio of 1.81 and a beta of 0.52. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The company's fifty day simple moving average is $447.15 and its two-hundred day simple moving average is $429.88.

Chemed (NYSE:CHE - Get Free Report) last issued its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business had revenue of $657.51 million for the quarter, compared to analyst estimates of $659.22 million. During the same quarter in the prior year, the business posted $5.63 EPS. The company's revenue for the quarter was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities research analysts predict that Chemed Corporation will post 22.67 earnings per share for the current fiscal year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were paid a dividend of $0.60 per share. The ex-dividend date was Thursday, May 28th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed's dividend payout ratio is presently 13.08%.

Insider Buying and Selling

In other Chemed news, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the transaction, the director owned 4,578 shares of the company's stock, valued at $2,047,876.74. This trade represents a 22.73% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares of the company's stock, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 3.33% of the company's stock.

Institutional Trading of Chemed

Several institutional investors have recently added to or reduced their stakes in CHE. Monetary Solutions Ltd acquired a new stake in shares of Chemed during the fourth quarter worth $25,000. Los Angeles Capital Management LLC acquired a new position in shares of Chemed in the 4th quarter valued at about $26,000. BOK Financial Private Wealth Inc. bought a new stake in shares of Chemed during the 4th quarter valued at about $27,000. Versant Capital Management Inc lifted its holdings in Chemed by 7,500.0% in the second quarter. Versant Capital Management Inc now owns 76 shares of the company's stock worth $35,000 after acquiring an additional 75 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB lifted its holdings in Chemed by 65.3% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company's stock worth $38,000 after acquiring an additional 32 shares during the last quarter. Institutional investors own 95.85% of the company's stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.